Related News
-
Mount Everest Climb Will Aid…
Thursday, March 4, 2010
Myles Clapsadl of Monroe Township, Cumberland County, has spent nearly all of his 17 years battling a degenerative… more...
-
2010 Request for Proposals:…
Tuesday, March 2, 2010
The Batten Disease Support and Research Association (BDSRA) is pleased to announce that limited funds are available to… more...
-
Bill Gates Gives Sh5 Billion…
Monday, February 22, 2010
Kampala -- The University of Glasgow has received a $3m (sh5.8b) grant from the Bill and Melinda Gates Foundation to… more...
-
Novartis Targets 3-Foot-Long…
Monday, January 25, 2010
Novartis AG wants to raise about $1 billion annually for 10 years to fund development of drugs against neglected… more...
-
EMA Starts Formal Review of…
Monday, January 25, 2010
AMSTERDAM, The Netherlands -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene… more...
News
-
CheckOrphan NewsFlash, March 2,…
3/02/2010
CheckOrphan NewsFlash for Tuesday, March 2, 2010: breaking news about rare diseases, orphan diseases, orphan drugs, and…
-
CheckOrphan NewsFlash January 15,…
1/15/2010
CheckOrphan NewsFlash for Friday, January 15, 2010: breaking news about rare diseases, orphan diseases, orphan drugs,…
-
CheckOrphan NewsFlash January 11,…
1/11/2010
CheckOrphan NewsFlash for Monday, January 11, 2010: breaking news about rare diseases, orphan diseases, orphan drugs,…
NewsFlash
More News
-
Mesothelioma That Killed Merlin Olsen…
SALT LAKE CITY -- Merlin Olsen passed away Wednesday from mesothelioma, but a doctor has… more...
-
Roche Provides Update on Phase III…
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the topline results of a phase III… more...
-
Ulcerative Colitis Product Granted…
Ulcerative colitis (UC) is a form of inflammatory bowel disease characterized by a… more...
-
Stimuvax Will Become Decision Resources…
WALTHAM, Mass. -- Decision Resources, one of the world's leading research and advisory… more...
-
PSA Test Reduces Prostate Cancer Deaths…
WASHINGTON -- When it comes to the documented 40 percent effectiveness of PSA… more...
Treatment News
EHE International and the Histiocytosis Association of America Want Americans to "Know the Facts" About Histiocytosis
| More
Tuesday, January 5, 2010
PITMAN, NJ -- EHE International and the Histiocytosis Association of America (HAA) are excited to announce the unveiling of a window display at 10 Rockefeller Plaza encouraging Americans to "Know the Facts" about histiocytosis.
Characterized by a build-up of white blood cells known as histiocytes, histiocytosis is a rare and potentially fatal blood disorder. The window will prominently feature images from the HAA's public awareness campaign including faces of patients diagnosed with histiocytosis.
"This opportunity will raise awareness among the public about the plight of histiocytosis and the need for federal research funding," said Executive Director Jeffrey Toughill. "It is important to know that the pain and suffering experienced by people with this disorder can be just as severe as that of people diagnosed with more prevalent diseases, such as leukemia. With the help of the public, physicians, and the family members and friends of patients with histiocytosis, we are able to offer hope for better treatments and a cure for all who suffer from histiocytosis."
The window will be on display for the public from January 4, 2010 until January 29, 2010. "EHE is pleased to offer the Histiocytosis Association of America this window in order to raise awareness for the need of better treatments and a cure of this rare, yet important, disease," said Deb McKeever, EHE President.
In addition to the faces of patients, the window will include important facts about histiocytosis. Approximately 1 in 560,000 adults and 1 in 200,000 children are diagnosed with the disorder in the United States each year. Histiocytosis is classified as an "orphan disease," because it affects too few people to receive government funding for research. Through its annual grant program, the HAA provides financial support to researchers studying the causes and treatment of the disorder.
Founded in 1986, the Histiocytosis Association of America is dedicated to raising awareness about histiocytic disorders, providing educational and emotional support, and funding research leading to better treatments and a cure. You can learn more about the HAA and histiocytosis at the HAA's website, www.histio.org. The site offers a variety of educational and emotional support services and information for patients diagnosed with histiocytosis, their friends and family members, physicians, and members of the public.
EHE International has been the recognized leader in employee and individual Preventive Healthcare Plans (PHP) specifically designed for the early identification of preventable disease and risk factors since 1913; clinical management of health findings; referral resources; and personal coaching intervention programs of adverse lifestyle behaviors associated with poor nutrition, physical inactivity, and smoking. It's nationally available PHP is a comprehensive, integrated approach to preventive healthcare for the reduction and management of future medical claims expense, increased productivity, and overall improved quality of life.
For more information, contact EHE International, 10 Rockefeller Plaza, 4th Floor, New York, New York 10020; 212.332.3702; www.EHEINTL.com.
Contact: Nicolas Danielides Danielides Communications Phone: 212-319-7566 Email: Email Contact
Contact: Jeffrey Toughill Histiocytosis Association of America Phone: 856-589-6606 Email: Email Contact
Source: Histiocytosis Association of America; EHE International
Log in to comment.